DotSpace biomedical Inc. devoting their talents to provide of Medical Internet of Thing (MIoT) solutions, integrating hardware, software and database systems, and expanding from clinical intensive care to other clinical monitoring and health examinations. DotSpace biomedical Inc. is a preclinical-stage company taking a targeted approach in the development of realtime wireless intra-abdominal hypertension monitoring system to improve critical intensive care. We are delveloping a capsulized pressure sensor effectively transmit data in monitoring key intra-abdominal pressure and motility believed to be involved in acute pancreatitis, trauma, infection and inflammatory bowel disorders.

Two distinct, first-in-class devices have been developed that precisely detect gastrointestinal physiological changes—with minimal invasive process that has little side effects seen with other methods from this class. DotSpace biomedical Inc. is positioned to deliver a intra-abdominal monitoring system for FDA approval approximately 12 months after program funding, and their intention is to pursue integration in standard intensive care monitoring system.

Promotional description of the business: heart disease is the number 1 reason for death in the US. The medical cost for heart failure will be $69B by 2030, and an estimated 26 million people suffer. As the entire world steps into an aging society, this problem will worsen and eventually make our healthcare system not sustainable. Our solution can effectively reduce the mortality rate and save medical costs by empowering patients to manage their health more effectively and help physicians take care of patients more efficiently.

Motivation for starting the business： I am a Leukemia survivor, and I spent lots of time in the hospital to fight my cancer. During a hospital stay at the University of California, San Diego (UCSD), I carefully observed clinical workflow and found many opportunities. Meanwhile, I have over 15 years of experience researching and commercializing Artificial Intelligence (AI) products; Qualcomm sponsored my Ph.D. Therefore, I decided to use AI to craft future healthcare and wish people like me could suffer less, eventually, fewer people like me.

Anavision is a new startup company that focuses on A.I. image analytics technologies. We develop world leading A.I. technologies for analyzing images and videos collected from Robots, Drones, Aircrafts and Satellites. Our aim is to free humans from jobs that can be done by a robot.
We differentiate ourselves from othe A.I. analytics companies by utilizing automated devices to collect proprietary A.I. learning datasets for training our A.I. algorithms. For example, we collect plantation image data from Oil Palm, Eucalyptus, Accacia, Cassava fields using drones in Indonesia, Cambodia and China, helping plantation companies to count their crops and analyze the health status of crops. These analytics data can help plantation companies to have better business insights in futures trading and risk management. Pests and disease detection using A.I. detects issues at an early stage, and using less pesticides in crops means less damages done to the Earth. We also use drone image data and Satellite image data to do Land Use analysis, helping governments to plan a better city for the residents.
During Covid-19 pandemic, we developed an A.I. Fever screening system, that helps to reduce the close contact of frontline staff and unknown visitors during temperature measurement.

HealTell, is focus to use mature technology in semiconductor industry, to design, manufacture and build super low cost, micro flow, precise infusion micro-fluidics MEMS pump with self-owned core IP, and apply for Bio-Medical market. We are building the 1st in China and world leading, ultra low cost precise insulin pump patch system, and in the future, it will extend to artificial pancreas, precise drug delivery system, IVF, cell culture and other Bio-Medical applications.

NCDs (Non Communicable Disorders) are the world’s no 1 killer – ie 38 million deaths every year.

Our GOAL is to reduce 25% premature deaths due to NCD’s by 2025

PROBLEM: Most of the current Cardiology screening devices (ECG, ECHO, Angio etc) are hospital-based and 10-100x costelier. However, for > 80% patients the 1st point of contact is at the primary care clinics. Hence, there is a huge MISSED OPPORTUNITY to detect Heart Disorders at the primary care clinics

SOLUTION: AiSteth is a smart stethoscope to screen, detect & predict Heart/Lung disorders using Ai/ML. It has got 3 key components:
i) Device – picks heart/lung sounds and converts them into visual wave patterns
ii) Data – the heart/lung sounds are streamed via bluetooth to a companion smart phone app for visualization + record, store and share capabilities
iii) Intelligence – ML algorithms run on top of the above two layers of device + data

4 SEGMENTS: Adult, Pediatric, Mother & Child, Co-morbidity

AiSteth has Covid indications as below:

1) for use by elderly at home
2) remote monitoring of Heart/Lung sounds for “at high-risk groups” with co morbidity (chronic heart and respiratory conditions)
3) use along tele-health, tele-medicine platforms for remote tracking of vitals

Worldwide, an estimated 3.6 billion diagnostic medical examinations are performed every year and there’s a severe shortage of radiologists who can interpret these scan. This leads to large influx of patients, understaffed radiology departments, and overworked radiologists.

In cognizance of this demand, we are developing a SAAS based artificial intelligence cloud platform that can reduce delays in diagnosis, facilitate earlier detection of diseases and reduce cost to patients.

We have been in the field of AI for the past 2.5 years, our passion, expertise and potential to impact global health experience has been well received and rewarded by esteemed organisations. We have previously reported the utility of using artificial intelligence in the early diagnosis of lung cancer from CT scans, lung abnormalities from chest x-rays and COVID-19 from CT scans and x-rays.

Our AI algorithm for Lung Nodule detection stood first in India in LUNA-16, an International AI hackathon and is currently being clinically validated at Tata Memorial, largest cancer hospital in India. Our work for covid is recognized by the government of India.

Our cloud infrastructure is supported by NVIDIA and Microsoft. Our technology is generic and can be extended to identify diseases from x-rays, CT, MRI, mammography and other modalities.

Swasthya aims to leverage technology to solve the challenge of workplace safety created by the pandemic.
It is a platform for businesses that helps them to
1. Make the employees feel safe
2. Brings back customers by gaining their trust

We do this through AI/ML and computer vision solutions that provide workplace safety ratings as well as key insights/recommendations on:
1. Covid health risk for customers and employees using IoT and voice analytics
2. Social distancing score
3. Mask compliance
4. Visitor location analytics
5. Contactless systems & processes score

Using this insights Swasthya empowers a business by
1. Allowing management to make data-driven decision to reduce risk at workplace
2. Driving revenue by gaining the trust of the customers to use their services

We are a dynamic startup with team members from prestigious universities like Cornell, Carnegie Mellon, IITs and IIMs.

We are Dozee, we specialise in a contact-free remote vitals monitoring. Our proprietary technology converts any bed into step-down ICU like vitals monitoring. Dozee tracks heart rate, respiration rate, blood pressure, sleep and stress levels without need for any wires or electrodes, with clinical grade accuracy. Just place under the mattress and sleep, the data is available over cloud interface to enable healthcare providers to provide continuous stream of health data.

We have over 5000 devices installed in hospitals and home and have provided care to over 20000 individuals, and has played a critical role in India’s fightback in the COVID pandemic empowering hospitals, Covid Care Centers and Quarantine Centers with proactive vitals monitoring.

Growing at 30% MoM, we are looking to serve 2500000 individuals in next 12 months.